Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Mir Ali to Opioid-Related Disorders

This is a "connection" page, showing publications Mir Ali has written about Opioid-Related Disorders.

 
Connection Strength
 
 
 
5.088
 
  1. Ali MM, Creedon TB, Jacobus-Kantor L, Sherry TB. National trends in buprenorphine prescribing before and during the COVID-19 pandemic. J Subst Abuse Treat. 2023 01; 144:108923.
    View in: PubMed
    Score: 0.644
  2. Ali MM, Ghertner R. Is buprenorphine treatment availability associated with decreases in substantiated cases of child maltreatment? J Subst Abuse Treat. 2022 08; 139:108780.
    View in: PubMed
    Score: 0.620
  3. Ali MM, Dubenitz J. Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015-2018. J Subst Abuse Treat. 2021 11; 130:108413.
    View in: PubMed
    Score: 0.579
  4. Ghertner R, Ali MM. Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019. Psychiatr Serv. 2020 09 01; 71(9):971.
    View in: PubMed
    Score: 0.545
  5. Meinhofer A, Hinde JM, Ali MM. Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings. J Subst Abuse Treat. 2020 03; 110:9-17.
    View in: PubMed
    Score: 0.527
  6. Ali MM, Tehrani AB, Mutter R, Henke RM, Cutler E, Pines JM, Mazer-Amirshahi M. Factors associated with potentially problematic opioid prescriptions among individuals with private insurance and medicaid. Addict Behav. 2019 11; 98:106016.
    View in: PubMed
    Score: 0.509
  7. Ali MM, Cutler E, Mutter R, Henke RM, O'Brien PL, Pines JM, Mazer-Amirshahi M, Diou-Cass J. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015. J Med Toxicol. 2019 07; 15(3):156-168.
    View in: PubMed
    Score: 0.508
  8. Ali MM, Henke RM, Mutter R, O'Brien PL, Cutler E, Mazer-Amirshahi M, Pines JM. Family member opioid prescriptions and opioid use disorder. Addict Behav. 2019 08; 95:58-63.
    View in: PubMed
    Score: 0.500
  9. West KD, Ali MM, Blanco M, Natzke B, Nguyen L. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System. Matern Child Health J. 2023 Dec; 27(Suppl 1):14-22.
    View in: PubMed
    Score: 0.167
  10. Sanmartin MX, McKenna RM, Ali MM, Krebs JD. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States. J Ment Health Policy Econ. 2020 Mar 01; 23(1):19-25.
    View in: PubMed
    Score: 0.134
  11. McClellan C, Fingar KR, Ali MM, Olesiuk WJ, Mutter R, Gibson TB. Price elasticity of demand for buprenorphine/naloxone prescriptions. J Subst Abuse Treat. 2019 11; 106:4-11.
    View in: PubMed
    Score: 0.129
  12. Novak P, Feder KA, Ali MM, Chen J. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey. J Subst Abuse Treat. 2019 03; 98:47-52.
    View in: PubMed
    Score: 0.123
  13. Naeger S, Ali MM, Mutter R, Mark TL, Hughey L. Prescriptions Filled Following an Opioid-Related Hospitalization. Psychiatr Serv. 2016 11 01; 67(11):1262-1264.
    View in: PubMed
    Score: 0.103
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.